AUTHOR=Mulder M. B. , Busschbach J. J. , van Hoek B. , Polak W. G. , Alwayn I. P. J. , de Winter B. C. M. , Murad S. Darwish , Verhey-Hart E. , Elshove L. , Erler N. S. , Hesselink D. A. , den Hoed C. M. , Metselaar H. J. 

TITLE=Tremors and Health-Related Quality of Life in Liver Transplant Recipients: Post-hoc Analysis of a Multicenter, Randomized, Controlled Trial Comparing a Life Cycle Pharma-Tacrolimus Regimen and Extended-Release Tacrolimus Regimen

JOURNAL=Transplant International

VOLUME=Volume 38 - 2025

YEAR=2025

URL=https://www.frontierspartnerships.org/journals/transplant-international/articles/10.3389/ti.2025.14189

DOI=10.3389/ti.2025.14189

ISSN=1432-2277

ABSTRACT=has received lecture fees and consulting fees from Chiesi Pharma and grant support from Astellas Pharma. M.B. Mulder does not have employment or stock ownership at any of these companies, and neither does he have patents or patent applications. D.A. Hesselink has received lecture fees and consulting fees from Astellas Pharma, Astra Zeneca, Chiesi Pharma, Medincell, Novartis Pharma, Sangamo Therapeutics and Vifor Pharma. He has received grant support from Astellas Pharma, Bristol-Myers Squibb and Chiesi Pharma (paid to his institution). D.A. Hesselink does not have employment or stock ownership at any of these companies, and neither does he have patents or patent applications. C.M. den Hoed has received lecture fees and consulting fees from Chiesi Pharma, Takeda, Novartis Pharma, Abacus medical and travel grants from Orphalan. C.M. den Hoed does not have employment or stock ownership at any of these companies, and neither does she have patents or patent applications. H.J. Metselaar has